{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:15:10Z","timestamp":1791231310116,"version":"4.1.0"},"reference-count":65,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2005,12,10]]},"abstract":"<jats:p>Lung cancer is the leading cause of cancer deaths in the United States and throughout the world; globally, there are more than 1.1 million deaths each year. Treatment modalities currently employed are significantly limited; 50% of patients experience disease recurrence after surgery, and less than a quarter of patients respond to systemic chemotherapy. These statistics have fueled the search for a safer, more effective treatment modality. Despite significant advances in our understanding of the molecular basis of cancer immunology, many obstacles remain. However, encouraging clinical results in patients immunized with autologous tumor cell vaccines expressing granulocyte macrophage colony-stimulating factor strongly advocate further investigation of immunotherapy in non\u2013small-cell lung cancer (NSCLC). Further studies are needed to demonstrate whether these novel therapies can potentially complement or even replace current therapeutic approaches. We present a review of the various vaccine-based strategies employed to target and treat NSCLC.<\/jats:p>","DOI":"10.1200\/jco.2005.02.3101","type":"journal-article","created":{"date-parts":[[2005,10,12]],"date-time":"2005-10-12T03:24:02Z","timestamp":1129087442000},"page":"9022-9028","source":"Crossref","is-referenced-by-count":50,"title":["Non\u2013Small-Cell Lung Cancer Vaccine Therapy: A Concise Review"],"prefix":"10.1200","volume":"23","author":[{"given":"Deirdre","family":"O'Mahony","sequence":"first","affiliation":[{"name":"From the Medical Oncology Clinical Research Unit, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaani","family":"Kummar","sequence":"additional","affiliation":[{"name":"From the Medical Oncology Clinical Research Unit, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"From the Medical Oncology Clinical Research Unit, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"BIB1","doi-asserted-by":"crossref","unstructured":"Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, CA Cancer J Clin 55:74,2002-108, 2005","DOI":"10.3322\/canjclin.55.2.74"},{"key":"BIB2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011954"},{"key":"BIB3","doi-asserted-by":"publisher","DOI":"10.1007\/BF02752256"},{"key":"BIB4","doi-asserted-by":"publisher","DOI":"10.1159\/000386035"},{"key":"BIB5","doi-asserted-by":"publisher","DOI":"10.1038\/35074122"},{"key":"BIB6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011223"},{"key":"BIB7","doi-asserted-by":"publisher","DOI":"10.1038\/nri1150"},{"key":"BIB8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1100369"},{"key":"BIB9","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-003-2185-x"},{"key":"BIB10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(70)80054-X"},{"key":"BIB11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197211162872004"},{"key":"BIB12","doi-asserted-by":"publisher","DOI":"10.3109\/08820138909030610"},{"key":"BIB13","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh028"},{"key":"BIB14","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(97)80078-7"},{"key":"BIB15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.4.1287"},{"key":"BIB16","doi-asserted-by":"crossref","unstructured":"Szabolcs P, Moore MA, Young JW: Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol 154:5851,1995-5861,","DOI":"10.4049\/jimmunol.154.11.5851"},{"key":"BIB17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.4.1292.bloodjournal8741292"},{"key":"BIB18","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<121::AID-IJC20>3.0.CO;2-X"},{"key":"BIB19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300531"},{"key":"BIB20","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(96)00079-8"},{"key":"BIB21","doi-asserted-by":"publisher","DOI":"10.1038\/nm0196-52"},{"key":"BIB22","doi-asserted-by":"publisher","DOI":"10.1006\/scbi.1998.0119"},{"key":"BIB23","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-001-0257-z"},{"key":"BIB24","doi-asserted-by":"crossref","unstructured":"Ueda Y, Itoh T, Nukaya I, et al: Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas. Int J Oncol 24:909,2004-917,","DOI":"10.3892\/ijo.24.4.909"},{"key":"BIB25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.4.629"},{"key":"BIB26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.141226398"},{"key":"BIB27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3539"},{"key":"BIB28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.4.755"},{"key":"BIB29","doi-asserted-by":"publisher","DOI":"10.1007\/s002620050506"},{"key":"BIB30","unstructured":"Jaffee EM, Dranoff G, Cohen LK, et al: High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res 53:2221,1993-2226,"},{"key":"BIB31","doi-asserted-by":"publisher","DOI":"10.1089\/10430340050015536"},{"key":"BIB32","doi-asserted-by":"publisher","DOI":"10.1080\/14653240310000074"},{"key":"BIB33","unstructured":"Dummer R: GVAX (Cell Genesys). Curr Opin Investig Drugs 2:844,2001-848,"},{"key":"BIB34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.091"},{"key":"BIB35","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.233"},{"key":"BIB36","doi-asserted-by":"publisher","DOI":"10.1126\/science.7678351"},{"key":"BIB37","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<244::AID-CNCR9>3.0.CO;2-L"},{"key":"BIB38","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.15.1159"},{"key":"BIB39","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19981209)78:6<685::AID-IJC4>3.0.CO;2-C"},{"key":"BIB40","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700641"},{"key":"BIB41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.197"},{"key":"BIB42","unstructured":"Hoover HC Jr, Surdyke M, Dangel RB, et al: Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guerin vaccine. Cancer Res 44:1671,1984-1676,"},{"key":"BIB43","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850315)55:6<1236::AID-CNCR2820550616>3.0.CO;2-#"},{"key":"BIB44","unstructured":"Schulof RS, Mai D, Nelson MA, et al: Active specific immunotherapy with an autologous tumor cell vaccine in patients with resected non-small cell lung cancer. Mol Biother 1:30,1988-36,"},{"key":"BIB45","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.486"},{"key":"BIB46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92542-2"},{"key":"BIB47","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1401"},{"key":"BIB48","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh220"},{"key":"BIB49","doi-asserted-by":"crossref","unstructured":"Grandis JR, Zeng Q, Drenning SD, et al: Normalization of EGFR mRNA levels following restoration of wild-type p53 in a head and neck squamous cell carcinoma cell line. Int J Oncol 13:375,1998-378,","DOI":"10.3892\/ijo.13.2.375"},{"key":"BIB50","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.106"},{"key":"BIB51","unstructured":"Pavelic K, Banjac Z, Pavelic J, et al: Evidence for a role of EGF receptor in the progression of human lung carcinoma. Anticancer Res 13:1133,1993-1137,"},{"key":"BIB52","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008261031034"},{"key":"BIB53","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg102"},{"key":"BIB54","doi-asserted-by":"crossref","unstructured":"Disis ML, Gralow JR, Bernhard H, et al: Peptide-based, but not whole protein, vaccines elicit immunity to HER-2\/neu, oncogenic self-protein. J Immunol 156:3151,1996-3158,","DOI":"10.4049\/jimmunol.156.9.3151"},{"key":"BIB55","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.1.202.202"},{"key":"BIB56","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.06.171"},{"key":"BIB57","unstructured":"Seregni E, Botti C, Lombardo C, et al: Pattern of mucin gene expression in normal and neoplastic lung tissues. Anticancer Res 16:2209,1996-2213,"},{"key":"BIB58","unstructured":"Peat N, Gendler SJ, Lalani N, et al: Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice. Cancer Res 52:1954,1992-1960,"},{"key":"BIB59","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1744"},{"key":"BIB60","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.397"},{"key":"BIB61","doi-asserted-by":"crossref","unstructured":"Kontani K, Taguchi O, Ozaki Y, et al: Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin. Int J Mol Med 12:493,2003-502,","DOI":"10.3892\/ijmm.12.4.493"},{"key":"BIB62","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200009000-00007"},{"key":"BIB63","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2001.n.018"},{"key":"BIB64","doi-asserted-by":"publisher","DOI":"10.1038\/nm1100"},{"key":"BIB65","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.3.205"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2005.02.3101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T02:04:33Z","timestamp":1683252273000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2005.02.3101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,10]]},"references-count":65,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2005,12,10]]}},"alternative-id":["10.1200\/JCO.2005.02.3101"],"URL":"https:\/\/doi.org\/10.1200\/jco.2005.02.3101","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,10]]}}}